Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROTIONAMIDE Cause Electrocardiogram qt prolonged? 94 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Electrocardiogram qt prolonged have been filed in association with PROTIONAMIDE. This represents 18.9% of all adverse event reports for PROTIONAMIDE.

94
Reports of Electrocardiogram qt prolonged with PROTIONAMIDE
18.9%
of all PROTIONAMIDE reports
10
Deaths
22
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From PROTIONAMIDE?

Of the 94 reports, 10 (10.6%) resulted in death, 22 (23.4%) required hospitalization, and 14 (14.9%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROTIONAMIDE. However, 94 reports have been filed with the FAERS database.

What Other Side Effects Does PROTIONAMIDE Cause?

Hepatotoxicity (88) Vomiting (68) Neuropathy peripheral (39) Off label use (39) Anaemia (36) Drug resistance (34) Aspartate aminotransferase increased (33) Nausea (33) Alanine aminotransferase increased (31) Hypokalaemia (25)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which PROTIONAMIDE Alternatives Have Lower Electrocardiogram qt prolonged Risk?

PROTIONAMIDE vs PROTONIX PROTIONAMIDE vs PROTOPIC PROTIONAMIDE vs PROVENGE PROTIONAMIDE vs PROVENTIL PROTIONAMIDE vs PROVERA

Related Pages

PROTIONAMIDE Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged PROTIONAMIDE Demographics